SVG Sprites

Press

LDPN In the News 03.01.2024

Federal Judge Dismisses Another Pharma Lawsuit

U.S. District Judge Colm Connolly’s decision today to dismiss AstraZeneca’s frivolous lawsuit is another big will for the Biden Administration and the millions of Medicare enrollees who will get lower drug costs under the new Medicare reforms passed in 2022. This is the third favorable ruling against legal challenges to Medicare negotiations and we remain confident that we’ll see a similar ruling in the upcoming hearing on March 7th in the New Jersey hearing during which Bristol Myers Squibb, Novo Nordisk, Novartis and Johnson & Johnson will present their oral arguments against Medicare negotiations.

LDPN In the News 02.09.2024

Pitchfork Economics: Medicare Drug Price Negotiations with Margarida Jorge

The pharmaceutical industry is one of the most opaque industries in America, and they take advantage of this lack of transparency by setting ever-higher prices for lifesaving prescription drugs like insulin. But provisions in the Inflation Reduction Act are curtailing the exorbitant price-gouging strategies that the pharmaceutical industry uses to pump up their profit margins at the expense of seniors and people with disabilities who use Medicare.

LDPN In the News 01.18.2024

The right medicine is life-changing, if you can afford it

I have seen firsthand how affordable medicine can transform families and communities. I grew up in Richmond, one of four children. My family members and I have experienced many of the health conditions that come from the trauma of racism in this city and nation.

LDPN In the News 09.08.2023

NC Newsline: It’s time to make prescription medications affordable for all

Last week, Medicare announced a list of ten drugs for lower drug price negotiations, kicking off a process that for the first time will require drug corporations to negotiate prices for some of the most expensive medicines in Medicare.

Under the new Medicare negotiations law,

LDPN In the News 07.11.2022

Quad-City Times: Grassley, Ernst explain opposition to Democratic prescription drug plan

DES MOINES — Iowa’s U.S. senators signaled opposition to a proposed plan from Senate Democrats aimed at lowering drug prices for Medicare recipients unveiled this week.

Sen. Joni Ernst and a spokesperson for Sen. Chuck Grassley, both Republicans, decried the plan as partisan in statements to the Lee Enterprises Des Moines Bureau.

LDPN In the News 07.01.2022

Lower Drug Prices Now on reports that Senate Democrats have reached a deal on prescription drug reform

This is a once in a generation chance for Democrats to finally deliver on their promises to lower drug prices. At a time when the price of everything is going up, this bill, if enacted, would finally rein in big Pharma’s price-gouging and make medicines more affordable for millions of Americans.

LDPN In the News 05.20.2022

Representative Susan Wild Leads Colleagues in Calling on Senate to Lower Prescription Drug Prices

Washington, DC – Yesterday, Representative Susan Wild, a champion for cutting costs for the people of Pennsylvania’s Seventh District, sent a letter signed by 19 colleagues, calling for Senate Majority Leader Chuck Schumer and Senate Committee on Finance Chairman Ron Wyden to provide relief for Americans by taking action to lower prescription drug prices through a reconciliation bill.

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles